Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Auxilium Pharmaceuticals, Inc.    AUXL   US05334D1072

SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 

Auxilium Pharmaceuticals, Inc. : and FCB I LLC File Lawsuit Against Watson for Infringement of Testim® Patents

05/24/2012 | 07:58am US/Eastern

MALVERN, Pa., and WILMINGTON, Del., May 24, 2012/PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) ("Auxilium") and FCB I LLC ("FCB") announced today that they filed a lawsuit against Watson Laboratories, Inc. (NV); Watson Pharmaceuticals, Inc.; and Watson Pharma, Inc. (collectively, "Watson") for infringement of FCB's ten patents listed in the U.S. Food and Drug Administration's ("FDA's") Approved Drug Products with Therapeutic Equivalence Evaluations (commonly known as the "Orange Book") as covering Testim® 1% testosterone gel.  The lawsuit was filed in the United States District Court for the District of New Jerseyon May 23, 2012.

Auxilium and FCB filed this lawsuit in response to a notice letter sent by Watson Laboratories, Inc. (NV) regarding its filing with the FDA of Abbreviated New Drug Application ("ANDA") No. 09

Recommend :
React to this article
2d ago AUXILIUM PHARMACEUTICALS : Change in Directors or Principal Officers (form 8-K)
2d ago AUXILIUM PHARMACEUTICALS : Regulation FD Disclosure, Financial Statements and Ex..
2d ago AUXILIUM PHARMACEUTICALS : Announces Positive Data From Phase 2a Study Of CCH In..
5d ago AUXILIUM PHARMACEUTICALS : Entry into a Material Definitive Agreement, Financial..
08/11 AUXILIUM PHARMACEUTICALS : Change in Directors or Principal Officers, Regulation..
08/11 AUXILIUM PHARMACEUTICALS : Appoints Andrew Saik Chief Financial Officer
08/07 AUXILIUM PHARMACEUTICALS : Results of Operations and Financial Condition, Regula..
08/07 AUXILIUM PHARMACEUTICALS : Announces Second Quarter 2014 Financial Results
08/06 AUXILIUM PHARMACEUTICALS : To Announce Second Quarter 2014 Results On August 7, ..
08/06 AUXILIUM PHARMACEUTICALS : Announces XIAFLEX Milestone: Partner Asahi Kasei Phar..
Duration : Period :
Auxilium Pharmaceuticals,  Technical Analysis Chart | AUXL | US05334D1072 | 4-Traders
Income Statement Evolution
Auxilium Pharmaceuticals,  : Income Statement Evolution
More Financials
Dynamic quotes